|
International Recall System Being Studied As Part of U.S. FDA International Pivot
SEATTLE — The U.S. Food and Drug Administration’s (FDA) Office of International Programs (OIP) is exploring development of a single, global recall system that would encompass all domestic and international recalls.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Subscribe
Archives